738 filings
Page 34 of 37
8-K
pvu6z u24m26x
6 Apr 06
Adventrx Presents Positive Thiovir Preclinical Results
12:00am
8-K/A
wpzhi3fchrnip1722e
27 Mar 06
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
UPLOAD
otow9lvp58r0zdilxy0o
21 Mar 06
Letter from SEC
12:00am
8-K
513f42ly87wzwf sxp5k
20 Mar 06
Adventrx Announces Thiovir Active Against H5N1 Avian Influenza Chimeric Virus Strains
12:00am
8-K
89jmzzia0rc
20 Mar 06
Adventrx to File Amended 2005 Third Quarter to Reflect Accounting for July 2005 Financing Under Eitf 00-19
12:00am
10-K
f6jbw aex5tvnar5sr5q
16 Mar 06
Annual report
12:00am
8-K
rr1oj7gcsazs7dr
1 Mar 06
Unregistered Sales of Equity Securities
12:00am
8-K
1uns8
15 Feb 06
CoFactor Clinical Update Announced at BIO CEO
12:00am
8-K
6jev5x
6 Feb 06
Entry into a Material Definitive Agreement
12:00am
8-K
cxlmccs8722
31 Jan 06
Adventrx Reports Thiovir Active Against Various Influenza a Viruses In Series of Independent Preclinical Tests
12:00am
8-K
enkb53 gc
30 Jan 06
ADVENTRX Announces Positive Efficacy and Safety Results from CoFactor Phase II Clinical Trial
12:00am
8-K
trui3ij8l3h gr
8 Dec 05
Adventrx Announces Positive Fda Pre-ind Meeting Outcome
12:00am
8-K
ud0brhcc1obcx spmgoe
7 Dec 05
Termination of a Material Definitive Agreement
12:00am
8-K
wycs7uk
29 Nov 05
Entry into a Material Definitive Agreement
12:00am
8-K
ca5mrm84pkatgcx8
18 Nov 05
Entry into a Material Definitive Agreement
12:00am
8-K
3vpn0k
7 Oct 05
Entry into a Material Definitive Agreement
12:00am